Temis, the provider of semantic content enrichment solutions for the Enterprise, has announced it has acquired the US-based i3 Analytics, a provider of advanced data analytics and visualisation technologies.
Founded in 2011 and employing former NIH (National Institutes of Health) engineers, i3 Analytics produces Biopharma Navigator, a software-as-a-service (SaaS) platform that charts the biopharma landscape based on life sciences open data.
Providing customers with tailor-made and intuitive visualisation maps, the product enables life sciences professionals to work faster, provide critical information to their peers, and make fast and informed clinical, regulatory, and business decisions.
Temis says the acquisition reinforces its commitment and capabilities to serving its customers by strengthening its product range with a complementary SaaS analytics and discovery offering and expanding its know-how with the integration of a team of former NIH engineers. The acquisition will also enable Temis to accelerate its penetration into new application areas in life sciences.